SlideShare a Scribd company logo
1 of 1
Download to read offline
Partial AZFc Microdeletions (gr/gr) of Y chromosome
in infertile males from South West of Iran
Background
Y chromosome microdeletion is the second most frequent cause of male infertility after the
Klinefelter syndrome. These microdeletions occur in the long arm of Y chromosome (Yq) in a
specific region known as azoospermia factor (AZF) including AZFa, AZFb, and AZFc
(Figure1). The most frequent complete microdeletion occurs in the AZFc which removes 3.5
Mb of the Y chromosome including 21 copies of genes. Among several partial microdeletions
reported in various researches, gr/gr deletion may have clinical relevance. Susceptibility of
AZFc region to non-homologous recombination leads to both partial deletions and
duplications which changes the gene dosage. This partial microdeletion removes almost half
of the AZFc gene content and leads to a range of spermatogenic phenotype from azoospermic
to normospermic. It seems that ethnic and geographical origin of the population and
Y chromosome background can affect the clinical outcome of this partial microdeletion.
Screening of Y chromosome microdeletions seems essential because not only these
microdeletions can lead to spermatogenesis failure, but also they are involved in recurrent
pregnancy loss. Furthermore, Deletions may transmit from infertile fathers to male offspring
when Assisted Reproductive Techniques (ART) are applied. Moreover, microdeletions in some
of these regions make sperm retrieval impossible for intra cytoplasmic injection. In Iran,
reports regarding the frequency of microdeletions vary considerably. The highest prevalence
(52%) of Y chromosome microdeletions was reported in azoospermic and oligospermic
patients from North of Iran, Rasht. The lowest frequency of these microdeletions observed in
Iran was 2.13% in Tehran. This discrepancy can be due to experimental errors. or various
approaches applied to determine the frequencies. The aim of this study was to investigate the
prevalence of Y chromosome microdeletions in South West of Iran using a standard method
applied by European Academy of Andrology/European Molecular Genetics Quality Network
(EAA/EMQN).
Methods
Subjects:
81 infertile males, including 53 non-obstructive azoospermic and 28 severe oligospermic
patients (sperm count of less than 5 × 106
) and 50 controls were included. The average age
was 35.8 in patients and 35 in controls. Patients were referred to Dr. Rostami's infertility
center from November 2013 to December 2015.
Analysis of complete microdeletions:
After signing the consent form, blood samples were obtained and stored in -20◦ C. Boiling
method was applied in order to extract the genomic DNA (Newton). Concentration and purity
of DNA was determined using Thermo Scientific TM Nanodrop spectrophotometer.
Two sets of Multiplex PCR (A and B) (Table1), suggested by EAA/EMQN, were applied to
detect the complete microdeletions of AZFa, AZFb, and AZFc regions. sY14 (SRY) was
applied as a positive control for the testis-determining factor located on the short arm of Y
chromosome. A fertile male and a female sample were also served as normal controls. A blank
sample was applied in PCR reactions as negative control. Both sets of multiplex PCR were
carried out using Amplicon Multiplex PCR Master Mix (containing HotStart Taq DNA
Polymerase, multiplex buffer with 1.5mM MgCl2 and dNTP mix). PCR products were run on
1.5% and 2% agarose gel for multiplex A and B, respectively. Ethidium bromide was used to
visualize the bands by UV tranilluminator.
Analysis of AZFc partial microdeletions:
To determine the gr/gr subdeletions, two STS primers, sY1291 and sY1191 (Table2), were
applied in a multiplex PCR reaction. Both primers were chosen according the EAA/EMNQ
suggestion to detect the gr/gr deletion. PCR products were run on 1.5% agarose gel Ethidium
bromide was used to visualize the bands by UV tranilluminator. The expected product size for
sY1191 and sY1291 were 385 bp and 527 bp, respectively. Presence of sY1191 and absence of
sY1291 confirms gr/gr deletions while the absence of sY1191 and presence of sY1291
represent another partial microdeletion called b2/b3 deletion (Figure2).
Results
Screening for complete Y chromosome microdeletions:
AZFa or AZFb complete deletion was not detected in any of patients in this study. One
azoospermic male out of 81 infertile males (1.2%) included in this study had complete
deletion of AZFc.
Screening for partial Y chromosome microdeletions:
After excluding the patient with complete deletion of AZFc, presence of partial microdeletion
of this region was investigated. In total, 6.25% (5 out of 80) of infertile males showed AZFc
partial microdeletions including 4 gr/gr (5%) and one b2/b3 subdeletion (1.25%). 2 out of 50
controls (4%) including normospermic and/or proven fathers showed gr/gr deletions while no
b2/b3 deletion was detected in controls.
Conclusion
In the current study, we followed EAA/EMQN procedure and detected 1.25% complete
microdeletions in our patients which is significantly lower than what has been reported in
other studies; but is consistent with the report by Saliminejad et al in 2012 that showed a
lower frequency of 2.13% of complete microdeletions.
Here, we observed 5% gr/gr deletions in our patients and 4% in our control group (proven
fathers and/or normospermic individuals). These results, suggest that in our study group, gr/gr
microdeletions may not be involved in spermatogenic failure. However, another partial
deletion, b2/b3 was detected in our patients with frequency of 1.25 % while no b2/b3 deletions
was detected in our control groups. Interestingly, Eloualid et al, reported the same frequency
(1.22%) for b2/b3 microdeletions in their infertile patients in a Chinese population. However,
we recommend a larger group of patients and controls to be screened for this microdeletion for
confirmation.
————————————————————–
Figures and Tables
Table1
Table2
Figure1 Figure2
Keywords
Infertility, Oligospermia, Azoospermia, AZF, Y chromosome, PCR, Microdeletion.
Shahryar Khorasani, Raheleh Masoudi, Liusa Mazaheri
Molecular Genetics Lab, Biology Department, School of Sciences, Shiraz University, Shiraz, Iran
Set A Size Set B Size
AZFa sY86 318 bp sY84 326 bp
AZFb sY127 274 bp sY134 301 bp
AZFc sY254 380 bp sY255 123 bp
Gr/gr sY1191 328 bp
Gr/gr sY1291 527 bp

More Related Content

What's hot

Dna methylation signature
Dna methylation signatureDna methylation signature
Dna methylation signatureNikunj tyagi
 
Mutations and detection of mutation using AuNP
Mutations and detection of mutation using AuNPMutations and detection of mutation using AuNP
Mutations and detection of mutation using AuNPRahul Mitra
 
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...dan079
 
Sequencing based approaches for profiling dna methylation
Sequencing based approaches for profiling dna methylationSequencing based approaches for profiling dna methylation
Sequencing based approaches for profiling dna methylationsciencelearning123
 
Inheritence of dna methylation
Inheritence of dna methylationInheritence of dna methylation
Inheritence of dna methylationsonam mahawar
 
The Role of DNA Methylation in Coronary Artery Disease
 The Role of DNA Methylation in Coronary Artery Disease The Role of DNA Methylation in Coronary Artery Disease
The Role of DNA Methylation in Coronary Artery DiseaseBardia Farivar
 
The role of DNA methylation in complex diseases
The role of DNA methylation in complex diseasesThe role of DNA methylation in complex diseases
The role of DNA methylation in complex diseasesJordana Bell
 
Gene expression and regulation
Gene expression and regulationGene expression and regulation
Gene expression and regulationDavid Enoma
 
Lectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesisLectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesisRishabh Jain
 
Epigenetic regulation in higher plants
Epigenetic regulation in higher plantsEpigenetic regulation in higher plants
Epigenetic regulation in higher plantsFOODCROPS
 
All about genes oncogenes mutations-cloning-gene therapy
All about genes oncogenes mutations-cloning-gene therapyAll about genes oncogenes mutations-cloning-gene therapy
All about genes oncogenes mutations-cloning-gene therapyAhmed Amer
 
pnas-0503504102
pnas-0503504102pnas-0503504102
pnas-0503504102Trinh Hoac
 

What's hot (19)

Corrected Review Paper
Corrected Review PaperCorrected Review Paper
Corrected Review Paper
 
Nitub workshop july 2018
Nitub workshop july 2018Nitub workshop july 2018
Nitub workshop july 2018
 
Dna methylation signature
Dna methylation signatureDna methylation signature
Dna methylation signature
 
Mutations and detection of mutation using AuNP
Mutations and detection of mutation using AuNPMutations and detection of mutation using AuNP
Mutations and detection of mutation using AuNP
 
508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...
 
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...
Detection of monoclonal immunoglobulin heavy chain gene rearrangement (fr3) i...
 
Sequencing based approaches for profiling dna methylation
Sequencing based approaches for profiling dna methylationSequencing based approaches for profiling dna methylation
Sequencing based approaches for profiling dna methylation
 
International Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & GynecologyInternational Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & Gynecology
 
20160218 hisham toma services
20160218 hisham toma services20160218 hisham toma services
20160218 hisham toma services
 
Inheritence of dna methylation
Inheritence of dna methylationInheritence of dna methylation
Inheritence of dna methylation
 
The Role of DNA Methylation in Coronary Artery Disease
 The Role of DNA Methylation in Coronary Artery Disease The Role of DNA Methylation in Coronary Artery Disease
The Role of DNA Methylation in Coronary Artery Disease
 
The role of DNA methylation in complex diseases
The role of DNA methylation in complex diseasesThe role of DNA methylation in complex diseases
The role of DNA methylation in complex diseases
 
Gene expression and regulation
Gene expression and regulationGene expression and regulation
Gene expression and regulation
 
Lectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesisLectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesis
 
transposon mediated mutagenesis
transposon mediated mutagenesistransposon mediated mutagenesis
transposon mediated mutagenesis
 
Epigenetic regulation in higher plants
Epigenetic regulation in higher plantsEpigenetic regulation in higher plants
Epigenetic regulation in higher plants
 
All about genes oncogenes mutations-cloning-gene therapy
All about genes oncogenes mutations-cloning-gene therapyAll about genes oncogenes mutations-cloning-gene therapy
All about genes oncogenes mutations-cloning-gene therapy
 
DNA Methylation
DNA MethylationDNA Methylation
DNA Methylation
 
pnas-0503504102
pnas-0503504102pnas-0503504102
pnas-0503504102
 

Viewers also liked

Chapter 8 Note Guide
Chapter 8 Note GuideChapter 8 Note Guide
Chapter 8 Note GuideTia Hohler
 
Chapter 19 study guide
Chapter 19 study guideChapter 19 study guide
Chapter 19 study guideTia Hohler
 
MRSM BM Kertas 1
MRSM BM Kertas 1MRSM BM Kertas 1
MRSM BM Kertas 1Azizi Net
 
Molecular and Human Genetics
Molecular and Human GeneticsMolecular and Human Genetics
Molecular and Human GeneticsTimothy Welsh
 
1 2 Note Guide
1 2 Note Guide1 2 Note Guide
1 2 Note GuideTia Hohler
 
MRSM BM Kertas 2
MRSM BM Kertas 2MRSM BM Kertas 2
MRSM BM Kertas 2Azizi Net
 

Viewers also liked (7)

Stl standards
Stl standardsStl standards
Stl standards
 
Chapter 8 Note Guide
Chapter 8 Note GuideChapter 8 Note Guide
Chapter 8 Note Guide
 
Chapter 19 study guide
Chapter 19 study guideChapter 19 study guide
Chapter 19 study guide
 
MRSM BM Kertas 1
MRSM BM Kertas 1MRSM BM Kertas 1
MRSM BM Kertas 1
 
Molecular and Human Genetics
Molecular and Human GeneticsMolecular and Human Genetics
Molecular and Human Genetics
 
1 2 Note Guide
1 2 Note Guide1 2 Note Guide
1 2 Note Guide
 
MRSM BM Kertas 2
MRSM BM Kertas 2MRSM BM Kertas 2
MRSM BM Kertas 2
 

Similar to Poster

Analysis of loss of heterozygosity of the tumor
Analysis of loss of heterozygosity of the tumorAnalysis of loss of heterozygosity of the tumor
Analysis of loss of heterozygosity of the tumorAlexander Decker
 
Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art...
 Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art... Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art...
Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art...Healthcare and Medical Sciences
 
Chromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal clubChromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal clubAIIMS
 
Insight into AZF region of y chromosome and male infertility
Insight into AZF region of y chromosome and male infertility Insight into AZF region of y chromosome and male infertility
Insight into AZF region of y chromosome and male infertility Shalaka Chitale
 
CRISPR cas9 mediated TERT disruption in cancer cells
CRISPR cas9 mediated TERT disruption in cancer cells CRISPR cas9 mediated TERT disruption in cancer cells
CRISPR cas9 mediated TERT disruption in cancer cells ChiLerFam
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...European School of Oncology
 
erica-HFI_mutation_poster-fin
erica-HFI_mutation_poster-finerica-HFI_mutation_poster-fin
erica-HFI_mutation_poster-finErica Ryu
 
NF2 frequency of mosaicism
NF2 frequency of mosaicismNF2 frequency of mosaicism
NF2 frequency of mosaicismBianca Heinrich
 
Verifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic LeukemiaVerifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic LeukemiaCharlotte Broadbent
 
journal.pone.0113435
journal.pone.0113435journal.pone.0113435
journal.pone.0113435Eric Chiou
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...European School of Oncology
 
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...Thermo Fisher Scientific
 
Cancer Res-2015-Bonastre-1287-97
Cancer Res-2015-Bonastre-1287-97Cancer Res-2015-Bonastre-1287-97
Cancer Res-2015-Bonastre-1287-97Sara Verdura
 
AJP_12-0313_Araten_et_al_Word_Version
AJP_12-0313_Araten_et_al_Word_VersionAJP_12-0313_Araten_et_al_Word_Version
AJP_12-0313_Araten_et_al_Word_VersionJonathan Karten
 
Lung adenocarcinoma -molecular pathology
Lung adenocarcinoma -molecular pathologyLung adenocarcinoma -molecular pathology
Lung adenocarcinoma -molecular pathologymlahori
 

Similar to Poster (20)

Analysis of loss of heterozygosity of the tumor
Analysis of loss of heterozygosity of the tumorAnalysis of loss of heterozygosity of the tumor
Analysis of loss of heterozygosity of the tumor
 
Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art...
 Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art... Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art...
Image analysis; Spinocellular carcinoma; Melanoma; Basal cell carcinoma; Art...
 
Chromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal clubChromosome 7 in lung cancer_Journal club
Chromosome 7 in lung cancer_Journal club
 
DOOR syndrome
DOOR syndromeDOOR syndrome
DOOR syndrome
 
Insight into AZF region of y chromosome and male infertility
Insight into AZF region of y chromosome and male infertility Insight into AZF region of y chromosome and male infertility
Insight into AZF region of y chromosome and male infertility
 
LAMB3(2014)
LAMB3(2014)LAMB3(2014)
LAMB3(2014)
 
CRISPR cas9 mediated TERT disruption in cancer cells
CRISPR cas9 mediated TERT disruption in cancer cells CRISPR cas9 mediated TERT disruption in cancer cells
CRISPR cas9 mediated TERT disruption in cancer cells
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
 
Autosomal dominant diseases
Autosomal dominant diseasesAutosomal dominant diseases
Autosomal dominant diseases
 
erica-HFI_mutation_poster-fin
erica-HFI_mutation_poster-finerica-HFI_mutation_poster-fin
erica-HFI_mutation_poster-fin
 
NF2 frequency of mosaicism
NF2 frequency of mosaicismNF2 frequency of mosaicism
NF2 frequency of mosaicism
 
Verifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic LeukemiaVerifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic Leukemia
 
Article_Subclones_BIG
Article_Subclones_BIGArticle_Subclones_BIG
Article_Subclones_BIG
 
2002_GT_PieriPC_Ydelq
2002_GT_PieriPC_Ydelq2002_GT_PieriPC_Ydelq
2002_GT_PieriPC_Ydelq
 
journal.pone.0113435
journal.pone.0113435journal.pone.0113435
journal.pone.0113435
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
 
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
 
Cancer Res-2015-Bonastre-1287-97
Cancer Res-2015-Bonastre-1287-97Cancer Res-2015-Bonastre-1287-97
Cancer Res-2015-Bonastre-1287-97
 
AJP_12-0313_Araten_et_al_Word_Version
AJP_12-0313_Araten_et_al_Word_VersionAJP_12-0313_Araten_et_al_Word_Version
AJP_12-0313_Araten_et_al_Word_Version
 
Lung adenocarcinoma -molecular pathology
Lung adenocarcinoma -molecular pathologyLung adenocarcinoma -molecular pathology
Lung adenocarcinoma -molecular pathology
 

Poster

  • 1. Partial AZFc Microdeletions (gr/gr) of Y chromosome in infertile males from South West of Iran Background Y chromosome microdeletion is the second most frequent cause of male infertility after the Klinefelter syndrome. These microdeletions occur in the long arm of Y chromosome (Yq) in a specific region known as azoospermia factor (AZF) including AZFa, AZFb, and AZFc (Figure1). The most frequent complete microdeletion occurs in the AZFc which removes 3.5 Mb of the Y chromosome including 21 copies of genes. Among several partial microdeletions reported in various researches, gr/gr deletion may have clinical relevance. Susceptibility of AZFc region to non-homologous recombination leads to both partial deletions and duplications which changes the gene dosage. This partial microdeletion removes almost half of the AZFc gene content and leads to a range of spermatogenic phenotype from azoospermic to normospermic. It seems that ethnic and geographical origin of the population and Y chromosome background can affect the clinical outcome of this partial microdeletion. Screening of Y chromosome microdeletions seems essential because not only these microdeletions can lead to spermatogenesis failure, but also they are involved in recurrent pregnancy loss. Furthermore, Deletions may transmit from infertile fathers to male offspring when Assisted Reproductive Techniques (ART) are applied. Moreover, microdeletions in some of these regions make sperm retrieval impossible for intra cytoplasmic injection. In Iran, reports regarding the frequency of microdeletions vary considerably. The highest prevalence (52%) of Y chromosome microdeletions was reported in azoospermic and oligospermic patients from North of Iran, Rasht. The lowest frequency of these microdeletions observed in Iran was 2.13% in Tehran. This discrepancy can be due to experimental errors. or various approaches applied to determine the frequencies. The aim of this study was to investigate the prevalence of Y chromosome microdeletions in South West of Iran using a standard method applied by European Academy of Andrology/European Molecular Genetics Quality Network (EAA/EMQN). Methods Subjects: 81 infertile males, including 53 non-obstructive azoospermic and 28 severe oligospermic patients (sperm count of less than 5 × 106 ) and 50 controls were included. The average age was 35.8 in patients and 35 in controls. Patients were referred to Dr. Rostami's infertility center from November 2013 to December 2015. Analysis of complete microdeletions: After signing the consent form, blood samples were obtained and stored in -20◦ C. Boiling method was applied in order to extract the genomic DNA (Newton). Concentration and purity of DNA was determined using Thermo Scientific TM Nanodrop spectrophotometer. Two sets of Multiplex PCR (A and B) (Table1), suggested by EAA/EMQN, were applied to detect the complete microdeletions of AZFa, AZFb, and AZFc regions. sY14 (SRY) was applied as a positive control for the testis-determining factor located on the short arm of Y chromosome. A fertile male and a female sample were also served as normal controls. A blank sample was applied in PCR reactions as negative control. Both sets of multiplex PCR were carried out using Amplicon Multiplex PCR Master Mix (containing HotStart Taq DNA Polymerase, multiplex buffer with 1.5mM MgCl2 and dNTP mix). PCR products were run on 1.5% and 2% agarose gel for multiplex A and B, respectively. Ethidium bromide was used to visualize the bands by UV tranilluminator. Analysis of AZFc partial microdeletions: To determine the gr/gr subdeletions, two STS primers, sY1291 and sY1191 (Table2), were applied in a multiplex PCR reaction. Both primers were chosen according the EAA/EMNQ suggestion to detect the gr/gr deletion. PCR products were run on 1.5% agarose gel Ethidium bromide was used to visualize the bands by UV tranilluminator. The expected product size for sY1191 and sY1291 were 385 bp and 527 bp, respectively. Presence of sY1191 and absence of sY1291 confirms gr/gr deletions while the absence of sY1191 and presence of sY1291 represent another partial microdeletion called b2/b3 deletion (Figure2). Results Screening for complete Y chromosome microdeletions: AZFa or AZFb complete deletion was not detected in any of patients in this study. One azoospermic male out of 81 infertile males (1.2%) included in this study had complete deletion of AZFc. Screening for partial Y chromosome microdeletions: After excluding the patient with complete deletion of AZFc, presence of partial microdeletion of this region was investigated. In total, 6.25% (5 out of 80) of infertile males showed AZFc partial microdeletions including 4 gr/gr (5%) and one b2/b3 subdeletion (1.25%). 2 out of 50 controls (4%) including normospermic and/or proven fathers showed gr/gr deletions while no b2/b3 deletion was detected in controls. Conclusion In the current study, we followed EAA/EMQN procedure and detected 1.25% complete microdeletions in our patients which is significantly lower than what has been reported in other studies; but is consistent with the report by Saliminejad et al in 2012 that showed a lower frequency of 2.13% of complete microdeletions. Here, we observed 5% gr/gr deletions in our patients and 4% in our control group (proven fathers and/or normospermic individuals). These results, suggest that in our study group, gr/gr microdeletions may not be involved in spermatogenic failure. However, another partial deletion, b2/b3 was detected in our patients with frequency of 1.25 % while no b2/b3 deletions was detected in our control groups. Interestingly, Eloualid et al, reported the same frequency (1.22%) for b2/b3 microdeletions in their infertile patients in a Chinese population. However, we recommend a larger group of patients and controls to be screened for this microdeletion for confirmation. ————————————————————– Figures and Tables Table1 Table2 Figure1 Figure2 Keywords Infertility, Oligospermia, Azoospermia, AZF, Y chromosome, PCR, Microdeletion. Shahryar Khorasani, Raheleh Masoudi, Liusa Mazaheri Molecular Genetics Lab, Biology Department, School of Sciences, Shiraz University, Shiraz, Iran Set A Size Set B Size AZFa sY86 318 bp sY84 326 bp AZFb sY127 274 bp sY134 301 bp AZFc sY254 380 bp sY255 123 bp Gr/gr sY1191 328 bp Gr/gr sY1291 527 bp